Patents by Inventor Thomas Marron

Thomas Marron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER BY ADMINISTERING A NEOADJUVANT PD-1 INHIBITOR
    Publication number: 20250346670
    Abstract: The present disclosure provides methods for treating, reducing the severity of, inhibiting the growth of a tumor, or inducing necrosis of a tumor, wherein the method includes selecting a patient with cancer (e.g., liver cancer, lung cancer, or head and neck cancer) in need thereof and administering to the patient a therapeutically effective amount of a programmed death 1 (PD-1) inhibitor (e.g., cemiplimab or abioequivalent thereof) as neoadjuvant therapy followed by surgical resection and optional administration of a programmed death 1 (PD-1) inhibitor (e.g., cemiplimab or a bioequivalent thereof) as post-surgery adjuvant therapy. In certain embodiments, the liver cancer is hepatocellular carcinoma (HCC), the lung cancer is non-small cell lung cancer (NSCLC), or the head and neck cancer is head and neck squamous cell carcinoma (HNSCC).
    Type: Application
    Filed: February 10, 2022
    Publication date: November 13, 2025
    Inventors: Elizabeth Miller, Israel Lowy, Gavin Thurston, Miriam Merad, Thomas Marron, Myron Schwartz
  • Antibacterial compounds with activity against penicillin-resistant streptococcus pneumoniae
    Publication number: 20040009932
    Abstract: Compounds which are useful as antibacterials for penicillin-resistant streptococcus pneumoniae and having formula (I) 1
    Type: Application
    Filed: April 23, 2003
    Publication date: January 15, 2004
    Inventors: Kathleen Phelan, Stevan Djuric, Zhenkun Ma, Thomas Marron, Hong Yong, Irini Zanze